Telix Pharmaceuticals Statistics
Total Valuation
TLX has a market cap or net worth of $6.33 billion. The enterprise value is $6.25 billion.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
TLX has 334.77 million shares outstanding. The number of shares has increased by 5.90% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 334.77M |
| Shares Change (YoY) | +5.90% |
| Shares Change (QoQ) | +4.39% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 284.92M |
Valuation Ratios
The trailing PE ratio is 204.85 and the forward PE ratio is 78.67.
| PE Ratio | 204.85 |
| Forward PE | 78.67 |
| PS Ratio | 13.06 |
| Forward PS | n/a |
| PB Ratio | 18.00 |
| P/TBV Ratio | 67.24 |
| P/FCF Ratio | 259.69 |
| P/OCF Ratio | 237.65 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 111.96, with an EV/FCF ratio of 256.32.
| EV / Earnings | 202.19 |
| EV / Sales | 12.89 |
| EV / EBITDA | 111.96 |
| EV / EBIT | 122.89 |
| EV / FCF | 256.32 |
Financial Position
The company has a current ratio of 2.78, with a Debt / Equity ratio of 1.02.
| Current Ratio | 2.78 |
| Quick Ratio | 2.57 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | 6.45 |
| Debt / FCF | 14.77 |
| Interest Coverage | 2.22 |
Financial Efficiency
Return on equity (ROE) is 13.92% and return on invested capital (ROIC) is 7.80%.
| Return on Equity (ROE) | 13.92% |
| Return on Assets (ROA) | 5.36% |
| Return on Invested Capital (ROIC) | 7.80% |
| Return on Capital Employed (ROCE) | 6.93% |
| Revenue Per Employee | $1.17M |
| Profits Per Employee | $74,439 |
| Employee Count | 415 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 9.87 |
Taxes
In the past 12 months, TLX has paid $3.80 million in taxes.
| Income Tax | 3.80M |
| Effective Tax Rate | 10.95% |
Stock Price Statistics
| Beta (5Y) | 2.38 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 16.72 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 68.66 |
| Average Volume (20 Days) | 18,817 |
Short Selling Information
The latest short interest is 22,061, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 22,061 |
| Short Previous Month | 16,489 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | 1.61 |
Income Statement
In the last 12 months, TLX had revenue of $484.69 million and earned $30.89 million in profits. Earnings per share was $0.09.
| Revenue | 484.69M |
| Gross Profit | 315.41M |
| Operating Income | 50.83M |
| Pretax Income | 20.66M |
| Net Income | 30.89M |
| EBITDA | 55.79M |
| EBIT | 50.83M |
| Earnings Per Share (EPS) | $0.09 |
Full Income StatementBalance Sheet
The company has $439.60 million in cash and $359.83 million in debt, giving a net cash position of $79.77 million or $0.24 per share.
| Cash & Cash Equivalents | 439.60M |
| Total Debt | 359.83M |
| Net Cash | 79.77M |
| Net Cash Per Share | $0.24 |
| Equity (Book Value) | 351.64M |
| Book Value Per Share | 1.05 |
| Working Capital | 363.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $26.63 million and capital expenditures -$17.81 million, giving a free cash flow of $24.37 million.
| Operating Cash Flow | 26.63M |
| Capital Expenditures | -17.81M |
| Free Cash Flow | 24.37M |
| FCF Per Share | $0.07 |
Full Cash Flow StatementMargins
Gross margin is 65.08%, with operating and profit margins of 10.49% and 6.37%.
| Gross Margin | 65.08% |
| Operating Margin | 10.49% |
| Pretax Margin | 7.16% |
| Profit Margin | 6.37% |
| EBITDA Margin | 11.51% |
| EBIT Margin | 10.49% |
| FCF Margin | 5.03% |